Want to join the conversation?
$VTR 1Q15 10-Q: On Jan. 16, 2015, Ventas acquired HCT in a stock & cash transaction which added 152 properties to its portfolio. As of March 31, 2015, Ventas had $451.9MM of borrowings outstanding, $13.3MM of letters of credit outstanding & $1.5Bil of unused borrowing capacity available under its unsecured revolving credit facility.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.